Skip to main
University-wide Navigation

New Collaboration Brings Translational Science to Criminal Justice Continuum

Researchers at the University of Arkansas for Medical Sciences (UAMS), the University of Kansas Medical Center (KUMC), and the University of Kentucky (UK) are teaming up to develop a new Clinical and Translational Science Award (CTSA) research network to support translational science across a criminal justice continuum that impacts millions of lives.

CRVAW and CCTS Launch Collaborative Pilot Program

A new program supported by the UK’s Center for Research on Violence Against Women (CRVAW) and Center for Clinical and Translational Science (CCTS) will provide seed funding for research projects that address violence against women.

Parents are 'Proud Our Daughters are Doing Their Part' in Vaccine Research Trial

Professor Stacy Stanifer enrolled her three daughters in the Moderna KidCOVE clinical trial to test the dosage and efficacy of the COVID-19 vaccine in children ages 6 months through 11 years old.

'UK at the Half': Philip Kern

UK Center for Clinical and Translational Science Director Philip Kern was featured during "UK at the Half," which aired during the UK vs. Missouri football game, broadcast on radio on September 11.

'Behind the Blue': Philip A. Kern Discusses UK’s Center for Clinical and Translational Science

On this episode of "Behind the Blue," CCTS Director Philip A. Kern, M.D., talks about the vast amount of work the center supports.

CCTS Debuts Comic Book on E-cigarette Use by Young Adults

A team at the UK Center for Clinical and Translational Science (CCTS) chose a novel approach to target e-cigarette use by young adults — a research-based comic book.

UK Receives $23.5 Million Clinical and Translational Science Award From the NIH

The University of Kentucky Center for Clinical and Translational Science (CCTS) has received a $23.5 million, four-year award from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health.

UK Selected as Site for COVID-19 Vaccine Booster Study

The University of Kentucky has been selected as a site for a trial to assess dose levels of a Johnson & Johnson booster shot.

Pharmacy Professor in Search of Treatments for Acute Kidney Injury

During Alex Flannery's tenure in critical care, the University of Kentucky College of Pharmacy assistant professor and 2011 graduate, saw many cases of sepsis and acute kidney injury, which have no cure. Flannery’s background in pharmacology sparked an interest in learning more about how to treat these diseases.

UK Research on Beige Fat Formation for Improved Glucose Metabolism Highlighted by NIDDK

Research led by Dr. Philip Kern was recently highlighted by the National Institute of Diabetes and Digestive and Kidney Diseases.